Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading
Over the last 3 months, CRVS insiders made 3 open-market buys and 0 sales, a net purchase of $334K (SEC Form 4). Over the last 6 months, 108 institutions increased and 57 reduced their position (13F).
Insider Activity
Sentiment
100/100
Buys (3m)
3
Sells (3m)
0
Net (3m)
$333.7K
Insiders buying
Insider trades by month Buys Sells
Dec
May
May
Jul
May
Jun
Context3-month price -24%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 15, 2026 | Grais Lindadirector | Grant | 15,000 | $11.60 |
| Jun 15, 2026 | Moore David Scottdirector | Buy | 21,700 | $11.53 |
| Jun 15, 2026 | Moore David Scottdirector | Grant | 15,000 | $11.60 |
| Jun 15, 2026 | CLARK IAN Tdirector | Grant | 15,000 | $11.60 |
| Jun 15, 2026 | van den Broek Richarddirector | Grant | 15,000 | $11.60 |
| Jun 15, 2026 | Thompson Peter A.director, 10 percent owner: | Grant | 15,000 | $11.60 |
| May 20, 2026 | MILLER RICHARD A MDdirector, officer: President and CEO | Buy | 5,000 | $12.05 |
| May 20, 2026 | MILLER RICHARD A MDdirector, officer: President and CEO | Buy | 1,932 | $12.01 |
| Apr 27, 2026 | Chan Andrew C.director | Grant | 30,000 | $16.02 |
| Jan 30, 2026 | Thompson Peter A.director, 10 percent owner: | Option | 30,000 | $15.00 |
| Jan 30, 2026 | Thompson Peter A.director, 10 percent owner: | Option | 15,000 | $2.12 |
| Dec 8, 2025 | MILLER RICHARD A MDdirector, officer: President and CEO | Grant | 1,000,000 | $8.81 |
| Dec 8, 2025 | Jones William Bentonofficer: See Remarks | Grant | 400,000 | $8.81 |
| Dec 8, 2025 | LEA LEIVofficer: Chief Financial Officer | Grant | 400,000 | $8.81 |
| Dec 8, 2025 | Arcara Jeffreyofficer: Chief Business Officer | Grant | 100,000 | $8.81 |
| Oct 6, 2025 | Moore David Scottdirector | Grant | 30,000 | $7.04 |
| Jul 1, 2025 | Thompson Peter A.director, 10 percent owner: | Sell | 1,176,332 | $4.16 |
| Jul 1, 2025 | ORBIMED ADVISORS LLCdirector, 10 percent owner: | Sell | 1,176,332 | $4.16 |
| Jun 16, 2025 | CLARK IAN Tdirector | Grant | 15,000 | $4.24 |
| Jun 16, 2025 | Grais Lindadirector | Grant | 15,000 | $4.24 |
| Jun 16, 2025 | Morrison Scott Wdirector | Grant | 15,000 | $4.24 |
| Jun 16, 2025 | Thompson Peter A.director, 10 percent owner: | Grant | 15,000 | $4.24 |
| Jun 6, 2025 | Jones William Bentonofficer: See Remarks | Option | 19,357 | $3.50 |
| May 9, 2025 | MILLER RICHARD A MDdirector, officer: President and CEO | Option | 559,073 | $3.50 |
| Apr 9, 2025 | van den Broek Richarddirector | Grant | 30,000 | $2.82 |
| Dec 23, 2024 | LEA LEIVofficer: Chief Financial Officer | Grant | 300,000 | $4.99 |
| Dec 23, 2024 | MILLER RICHARD A MDdirector, officer: President and CEO | Grant | 750,000 | $4.99 |
| Dec 23, 2024 | Arcara Jeffreyofficer: Chief Business Officer | Grant | 50,000 | $4.99 |
| Dec 23, 2024 | Jones William Bentonofficer: See Remarks | Grant | 300,000 | $4.99 |
| Jun 17, 2024 | Grais Lindadirector | Grant | 15,000 | $2.12 |
Source: CRVS SEC Form 4 filings, latest Jun 15, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CRVS positions over the last 6 months (SEC Form 13F).
Increased
108
New positions
91
Reduced
57
Sold out
31
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| ORBIMED ADVISORS LLC | Unchanged | 7.2M | May 15, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 7.2M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 6.2M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5.1M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 3.9M | Jan 29, 2026 |
| MORGAN STANLEY | Increased | 3.6M | Feb 13, 2026 |
| STATE STREET CORP | Increased | 3.6M | May 15, 2026 |
| ADAMS STREET PARTNERS LLC | Unchanged | 3.3M | May 15, 2026 |
| ADAMS STREET PARTNERS LLC | Unchanged | 3.3M | Feb 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3.2M | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 2.9M | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 2.9M | Feb 17, 2026 |
| VIVO CAPITAL, LLC | Increased | 2.8M | May 20, 2026 |
| STATE STREET CORP | Increased | 2.8M | Feb 13, 2026 |
| BIOIMPACT CAPITAL LLC | New Position | 2.7M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.